Carlyle has more than 600 corporate and real estate investments in our global portfolio. Selected current and exited (former) investments can be reviewed by fund, industry and geography.
Carlyle Asia Growth Partners III Acquired: March 2006 Status:
Current
Claris Lifesciences Limited manufactures and markets sterile parenteral preparations, life saving medicines and other hospital care products. Claris has a special focus on the delivery systems used for administering these drugs and has developed specialized products in that area.